We established the UCSF Clinical and Translational Science Institute (CTSI) at the University of California, San Francisco (UCSF) in 2006 to accelerate the pace of research that improves the health of the public. The overall mission of CTSI has been to improve and transform clinical and translational research infrastructure and training at UCSF and our partner institutions. In the next funding period we aim to use the substantial knowledge, skills, and infrastructure that we have developed to further accelerate the pace of research at UCSF, to export our successes to other institutions, and to create initiatives aimed at improving the health of our own and other communities, through the following aims:
SPECIFIC AIM 1 : To enhance the highly successful activities of the UCSF CTSI, including the development of new initiatives in the areas of Training, Infrastructure/Services, and Advocacy/Culture Change: a) Training: to provide programs for students at all levels, across a spectrum of settings, and including all phases of the improvement of healthcare;b) Infrastructure/Services: to expand services and tools to clinical and translational investigators at UCSF, our partner institutions, and within the broader regional, national, and global communities;and, c) Advocacv/Culture Change: to nurture communication, encourage collaboration, foster innovation, and catalyze the successful conduct of clinical and translational research;to support a diverse faculty;to increase involvement of the community and the responsive of research to its needs;and change the academic culture to promote multidisciplinary, collaborative work.
SPECIFIC AIM 2 : To develop crosscutting initiatives using the knowledge, skills, and infrastructure developed by multiple CTSI programs in the first funding period to accelerate clinical and translational research and its impact on health, well beyond the institutions collaborating in the UCSF CTSI. New initiatives will: a) Bring together local public health and philanthropic groups to work with CTSI to improve the health of the San Francisco Bay Area community through a series of health improvement projects directed at high impact conditions;b) create a model system to accelerate the pace of clinical and translational research that includes streamlining regulation, developing participant recruitment services, providing research management, and bringing research services directly into community practices;and, c) improve the performance, transparency and accountability of research administration within and beyond CTSI by setting challenging goals and tracking performance metrics on public dashboards.
These aims will be achieved by orchestration of activities occurring within and between our 10 programs, supported by a proven governance model, and with strong ties to institutional and community leadership. Our ultimate goal is to bring better health to more people more quickly.
CTSI aims to bring better health to more people more quickly by supporting training, infrastructure, advocacy, and culture change. CTSI achieves this goal not by conducting research but by making it easier for UCSF's superb investigators to conduct research. The current infrastructure and policy environment for clinical and translational research is inefficient, cumbersome and even obstructionist, so CTSI can only meet its goals if it also transforms the way research is done. Its goal is to build innovative infrastructure, tools and services, to transform the core university culture to one which promotes and rewards collaboration and accelerate the clinical application of basic science.
|Sullivan, Kathleen M; Dawson Rose, Carol; Phillips, J Craig et al. (2017) Sexual transmission-risk behaviour among HIV-positive persons: a multisite study using social action theory. J Adv Nurs 73:162-176|
|Weinstein, John R; Asteria-Peñaloza, Renée; Diaz-Artiga, Anaité et al. (2017) Exposure to polycyclic aromatic hydrocarbons and volatile organic compounds among recently pregnant rural Guatemalan women cooking and heating with solid fuels. Int J Hyg Environ Health 220:726-735|
|Schaller, Melinda S; Zahner, Greg J; Gasper, Warren J et al. (2017) Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements. J Clin Lipidol 11:1289-1295|
|Andrews, James S; Trupin, Laura; Hough, Catherine L et al. (2017) Serum biomarkers of inflammation and muscle strength among women with systemic lupus erythematosus. Cytokine 90:109-112|
|Zahner, Greg J; Gruendl, Magdalena A; Spaulding, Kimberly A et al. (2017) Association between arterial stiffness and peripheral artery disease as measured by radial artery tonometry. J Vasc Surg 66:1518-1526|
|St Helen, Gideon; Dempsey, Delia A; Havel, Christopher M et al. (2017) Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes. Drug Alcohol Depend 178:391-398|
|Mangurian, Christina; Niu, Grace C; Schillinger, Dean et al. (2017) Utilization of the Behavior Change Wheel framework to develop a model to improve cardiometabolic screening for people with severe mental illness. Implement Sci 12:134|
|Browning, Matthew G; Rabl, Charlotte; Campos, Guilherme M (2017) Blunting of adaptive thermogenesis as a potential additional mechanism to promote weight loss after gastric bypass. Surg Obes Relat Dis 13:669-673|
|Stuart, Sarah E; Schoen, Patrick; Jin, Chengshi et al. (2017) Tumor recurrence of keratinocyte carcinomas judged appropriate for Mohs micrographic surgery using Appropriate Use Criteria. J Am Acad Dermatol 76:1131-1138.e1|
|Drudi, Laura M; Schaller, Melinda S; Hiramoto, Jade et al. (2017) Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease. J Surg Res 210:124-131|
Showing the most recent 10 out of 620 publications